Ganglioside GM1 effects on the expression of nerve growth factor (NGF), Trk-A receptor, proinflammatory cytokines and on autoimmune diabetes onset in non-obese diabetic (NOD) mice

Cytokine

Volumn 42, Issue 1, 2008, Pages 92-104

  Vieira, Karla Priscila ^a   de Almeida e Silva Lima Zollner, Ana Rachel ^a   Malaguti, Carina ^a   Vilella, Conceição Aparecida ^a   de Lima Zollner, Ricardo ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cytokines; Gangliosides; NGF; NOD mice and autoimmune diabetes; Peri islet Schwann cells; TrkA

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GANGLIOSIDE GM1 ANTIBODY; GLIAL FIBRILLARY ACIDIC PROTEIN; INTERLEUKIN 12; INTERLEUKIN 1BETA; NERVE GROWTH FACTOR; PROTEIN S100B; PROTEIN TYROSINE KINASE A; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MECHANISM; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL;

AGE OF ONSET; ANIMALS; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; G(M1) GANGLIOSIDE; HUMANS; ISLETS OF LANGERHANS; MALE; MICE; MICE, INBRED NOD; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RECEPTOR, TRKA; S100 PROTEINS; SCHWANN CELLS; SPLEEN;

MUS;

EID: 41149168525     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2008.01.009     Document Type: Article

References (59)

1. Leiter E.H. The NOD mouse: a model for insulin-dependent diabetes mellitus. Curr. Protoc. Immunol. 24 (1997) 21-24
2. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., and Tochino Y. Breeding of a non-obese, diabetic strain of mice. Jikken Dobutsu 29 (1980) 1-13
3. Kikutani H., and Makino S. The murine autoimmune diabetes model: NOD and related strains. Adv Immunol 51 (1992) 285-322
4. Anderson M.S., and Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu Rev Immunol 23 (2005) 447-485
5. Rabinovitch A., and Suarez-Pinzon W.L. Role of cytokines in the pathogenesis of autoimmune diabetes mellitus. Rev Endocr Metab Disord 4 (2003) 291-299
6. Wachlin G., Augstein P., Schroder D., Kuttler B., Kloting I., Heinke P., et al. IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J Autoimmun 20 (2003) 303-312
7. Winer S., Tsui H., Lau A., Song A., Li X., Cheung R.K., et al. Autoimmune islet destruction in spontaneous type 1 diabetes is not beta-cell exclusive. Nat Med 9 (2003) 198-205
8. Persson-Sjogren S., Holmberg D., and Forsgren S. Remodeling of the innervation of pancreatic islets accompanies insulitis preceding onset of diabetes in the NOD mouse. J Neuroimmunol 158 (2005) 128-137
9. Levi-Montalcini R. The nerve growth factor: thirty-five years later. Biosci Rep 7 (1987) 681-699
10. Aloe L. Nerve growth factor and neuroimmune responses: basic and clinical observations. Arch Physiol Biochem 109 (2001) 354-356
11. Aloe L., Simone M.D., and Properzi F. Nerve growth factor: a neurotrophin with activity on cells of the immune system. Microsc Res Tech 45 (1999) 285-291
12. Sariola H. The neurotrophic factors in non-neuronal tissues. Cell Mol Life Sci 58 (2001) 1061-1066
13. Meakin S.O., and Shooter E.M. The nerve growth factor family of receptors. Trends Neurosci 15 (1992) 323-331
14. Navarro-Tableros V., Sanchez-Soto M.C., Garcia S., and Hiriart M. Autocrine regulation of single pancreatic beta-cell survival. Diabetes 53 (2004) 2018-2023
15. Rosenbaum T., Vidaltamayo R., Sanchez-Soto M.C., Zentella A., and Hiriart M. Pancreatic beta cells synthesize and secrete nerve growth factor. Proc Natl Acad Sci USA 95 (1998) 7784-7788
16. Rausa F.M., Ye H., Lim L., Duncan S.A., and Costa R.H. In situ hybridization with 33P-labeled RNA probes for determination of cellular expression patterns of liver transcription factors in mouse embryos. Methods 16 (1998) 29-41
17. Singh J., Adeghate E., Salido G.M., Pariente J.A., Yago M.D., and Juma L.O. Interaction of islet hormones with cholecystokinin octapeptide-evoked secretory responses in the isolated pancreas of normal and diabetic rats. Exp Physiol 84 (1999) 299-318
18. Mocchetti I. Exogenous gangliosides, neuronal plasticity and repair, and the neurotrophins. Cell Mol Life Sci 62 (2005) 2283-2294
19. Tettamanti G. Ganglioside/glycosphingolipid turnover: new concepts. Glycoconj J 20 (2004) 301-317
20. Monteiro de Castro G., Eduarda Zanin M., Ventura-Oliveira D., Aparecida Vilella C., Ashimine R., and de Lima Zollner R. Th1 and Th2 cytokine immunomodulation by gangliosides in experimental autoimmune encephalomyelitis. Cytokine 26 (2004) 155-163
21. Papaccio G., Chieffi Baccari G., and Mezzogiorno V. In vivo effect of gangliosides on non-obese diabetic mice. Acta Anat (Basel) 147 (1993) 168-173
22. Offner H., Thieme T., and Vandenbark A.A. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J Immunol 139 (1987) 3295-3305
23. Saggioro D., Sorio C., Calderazzo F., Callegaro L., Panozzo M., Berton G., et al. Mechanism of action of the monosialoganglioside GM1 as a modulator of CD4 expression. Evidence that GM1-CD4 interaction triggers dissociation of p56lck from CD4, and CD4 internalization and degradation. J Biol Chem 268 (1993) 1368-1375
24. Maysinger D., Filipovic-Grcic J., and Cuello A.C. Effects of coencapsulated NGF and GM1 in rats with cortical lesions. Neuroreport 4 (1993) 971-974
25. Rabin S.J., and Mocchetti I. GM1 ganglioside activates the high-affinity nerve growth factor receptor trkA. J Neurochem 65 (1995) 347-354
26. Rabin S.J., Bachis A., and Mocchetti I. Gangliosides activate Trk receptors by inducing the release of neurotrophins. J Biol Chem 277 (2002) 49466-49472
27. Pavin E.J., and Zollner R.L. Implantação da linhagem NOD mice (camundongos diabéticos não-obesos) no Brasil: contribuição deste modelo animal ao estudo o diabetes mellitus insulino-dependente e outras doenças autoimunes. Arq Bras Endocrinol Metabol 38 (1994) 105-108
28. Jones M.L. Lipids. In: Bancroft J.D.G.M. (Ed). Theory and practice of histology techniques. 5th ed. (2002), Churchil Livingstone, New York 201-230
29. Rodriguez P.E., and Cumar F.A. Gangliosides noncovalently bound to DEAE-Sephadex: application to purification of anti-ganglioside antibodies. Anal Biochem 188 (1990) 48-52
30. Gotoh M., Maki T., Kiyoizumi T., Satomi S., and Monaco A.P. An improved method for isolation of mouse pancreatic islets. Transplantation 40 (1985) 437-438
31. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
32. Ventura-Oliveira D., Vilella C.A., Zanin M.E., Castro G.M., Moreira Filho D.C., and Zollner R.L. Kinetics of TNF-alpha and IFN-gamma mRNA expression in islets and spleen of NOD mice. Braz J Med Biol Res 35 (2002) 1347-1355
33. Miao G., Mace J., Kirby M., Hopper A., Peverini R., Chinnock R., et al. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation 81 (2006) 519-524
34. + T lymphocytes: clarification of their pathogenic roles in diabetes in the NOD mouse. Res Immunol 148 (1997) 320-327
35. Thomas H.E., and Kay T.W. Beta cell destruction in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. Diabetes Metab Res Rev 16 (2000) 251-261
36. Wong F.S., and Janeway Jr. C.A. The role of CD4 and CD8 T cells in type I diabetes in the NOD mouse. Res Immunol 148 (1997) 327-332
37. Merritt W.D., Bailey J.M., and Pluznik D.H. Inhibition of interleukin-2-dependent cytotoxic T-lymphocyte growth by gangliosides. Cell Immunol 89 (1984) 1-10
38. Repke H., Barber E., Ulbricht S., Buchner K., Hucho F., Kopp R., et al. Ganglioside-induced CD4 endocytosis occurs independent of serine phosphorylation and is accompanied by dissociation of P56lck. J Immunol 149 (1992) 2585-2591
39. Grayson G., and Ladisch S. Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity. Cell Immunol 139 (1992) 18-29
40. Rosenbaum T., Castanares D.T., Lopez-Valdes H.E., and Hiriart M. Nerve growth factor increases L-type calcium current in pancreatic beta cells in culture. J Membr Biol 186 (2002) 177-840
41. Rampersaud A.A., Oblinger J.L., Ponnappan R.K., Burry R.W., and Yates A.J. Gangliosides and growth factor receptor regulation. Biochem Soc Trans 27 (1999) 415-422
42. Wang Y., Tsui Z., and Yang F. Antagonistic effect of ganglioside GM1 and GM3 on the activity and conformation of sarcoplasmic reticulum Ca(2+)-ATPase. FEBS Lett 457 (1999) 144-148
43. Sunami E., Kanazawa H., Hashizume H., Takeda M., Hatakeyama K., and Ushiki T. Morphological characteristics of Schwann cells in the islets of Langerhans of the murine pancreas. Arch Histol Cytol 64 (2001) 191-201
44. Molotkovskaya I.M., Kholodenko R.V., and Molotkovsky J.G. Influence of gangliosides on the IL-2- and IL-4-dependent cell proliferation. Neurochem Res 27 (2002) 761-770
45. Bharti A.C., and Singh S.M. Induction of apoptosis in bone marrow cells by gangliosides produced by a T cell lymphoma. Immunol Lett 72 (2000) 39-48
46. Venkataraman K., and Futerman A.H. Ceramide as a second messenger: sticky solutions to sticky problems. Trends Cell Biol 10 (2000) 408-412
47. Bretzel R.G., Flesch B.K., Willig J., Woehrle M., and Federlin K. Effects of ganglioside (Cronassial) treatment on MHC Ia antigen expression and allograft survival of pancreatic islets in diabetic rats. Diabetologia 33 (1990) 112-114
48. Heitger A., and Ladisch S. Gangliosides block antigen presentation by human monocytes. Biochim Biophys Acta 1303 (1996) 161-168
49. Hanai N., Nakamura K., and Shitara K. Recombinant antibodies against ganglioside expressed on tumor cells. Cancer Chemother Pharmacol 46 Suppl. (2000) S13-S17
50. Raile K., Klammt J., Laue S., Garten A., Bluher M., Kralisch S., et al. Glucose concentration and AMP-dependent kinase activation regulate expression of insulin receptor family members in rat islets and INS-1E beta cells. Diabetologia 48 (2005) 1798-1809
51. Pierucci D., Cicconi S., Bonini P., Ferrelli F., Pastore D., Matteucci C., et al. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro. Diabetologia 44 (2001) 1281-1295
52. Raile K., Klammt J., Garten A., Laue S., Bluher M., Kralisch S., et al. Glucose regulates expression of the nerve growth factor (NGF) receptors TrkA and p75NTR in rat islets and INS-1E beta-cells. Regul Pept 135 (2006) 30-38
53. Rosenbaum T., Castanares D.T., Lopez-Vaides H.E., and Hiriart M. Nerve growth factor increases L-type calcium current in pancreatic beta cells in culture. J Membr Biol 186 (2002) 177-184
54. Mallei A., Rabin S.J., and Mocchetti I. Autocrine regulation of nerve growth factor expression by Trk receptors. J Neurochem 90 (2004) 1085-1093
55. Kakinoki B., Sekimoto S., Yuki S., Ohgami T., Sejima M., Yamagami K., et al. Orally active neurotrophin-enhancing agent protects against dysfunctions of the peripheral nerves in hyperglycemic animals. Diabetes 55 (2006) 616-621
56. Bradley L.M., Asensio V.C., Schioetz L.K., Harbertson J., Krahl T., Patstone G., et al. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes. J Immunol 162 (1999) 2511-2520
57. Hirai H., Kaino Y., Ito T., and Kida K. Analysis of cytokine mRNA expression in pancreatic islets of nonobese diabetic mice. J Pediatr Endocrinol Metab 13 (2000) 91-98
58. O'Hara Jr. R.M., Henderson S.L., and Nagelin A. Prevention of a Th1 disease by a Th1 cytokine: IL-12 and diabetes in NOD mice. Ann NY Acad Sci 795 (1996) 241-249
59. Yang X.D., Tisch R., Singer S.M., Cao Z.A., Liblau R.S., Schreiber R.D., et al. Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180 (1994) 995-1004